Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-095-2 | CAS number: 605-71-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation, other
- Remarks:
- Not Applicable (Q)SAR - structural analysis only
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Study period:
- 03 Oct 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- The (Q)SARs models used in this assessment have been evaluated by the Joint Research Centre (JRC) and the scientific validity of each software established according to five principles recommended by OECD and ECHA for regulatory purposes (Annex XI of the REACH).
At present, a summary of appropriate information on the (Q)SAR models, based on the topics listed below, is not available in a specific reporting format.
• • Endpoint, algorithm
• • Domain of applicability
• • Measures related to goodness-of-fit
• • Robustness
• • Predictivity and mechanism
However, the adequacy and reliability of each (Q)SAR prediction was checked for each endpoint following the procedures outlined in REACH Annex XI (1.3) in terms of suitability of the model (reliability, relevance for the purpose), applicability of the model to the substance of interest and adequacy of the predicted endpoint for classification and labelling.
See attached justification for further information.
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- (Q)SAR analysis using valid models - no guideline required.
- GLP compliance:
- no
- Justification for non-LLNA method:
- (Q)SAR analysis using valid models. No animals used.
Test material
- Reference substance name:
- 1,5-dinitronaphthalene
- EC Number:
- 210-095-2
- EC Name:
- 1,5-dinitronaphthalene
- Cas Number:
- 605-71-0
- Molecular formula:
- C10H6N2O4
- IUPAC Name:
- 1,5-dinitronaphthalene
- Test material form:
- other: In SIlico
- Details on test material:
- In silico test item
Constituent 1
- Specific details on test material used for the study:
- Not applicable - (Q)SAR analysis
In vivo test system
Test animals
- Species:
- other: (Q)SAR analysis
- Strain:
- other: (Q)SAR analysis
- Sex:
- not specified
- Details on test animals and environmental conditions:
- Not Applicable (Q)SAR - structural analysis only
Results and discussion
- Positive control results:
- Not Applicable (Q)SAR - structural analysis only, no tissue dependance
In vitro / in chemico
Results
- Key result
- Run / experiment:
- other: (Q)SAR - structural analysis
- Parameter:
- other: (Q)SAR - structural analysis
- Vehicle controls validity:
- other: Not aplicable: (Q)SAR
- Negative controls validity:
- other: Not aplicable: (Q)SAR
- Positive controls validity:
- other: Not aplicable: (Q)SAR
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Despite the lack of animal testing data for this endpoint, the weight of evidence approach suggests classification of 1,5-dinotronapthalene as a skin sensitiser category 1B.
Any other information on results incl. tables
The skin sensitisation potential of a substance is related to its intrinsic ability to react with proteins and consequently to form covalently linked conjugates that should be recognised by the human immune system (ECHA, 2016a). This property is largely dependent on the electrophilic reactivity of the chemical. To take into account this aspect, various types of electrophile-nucleophile reactions of skin sensitisation comprise the domain of applicability used by some (Q)SAR models. Accordingly, the first screening for skin sensitisation of 1,5-dinitronapthalene was performed using specific endpoints and protein binding profilers in the OECD Toolbox, such as OASIS v 1.3, OASIS v1.4 and OECD. None of these endpoints triggered alerts for electrophile-nucleophile type reactions, including the “reactivity mode of action” endpoint in Toxtree.
Further qualitative (Q)SAR predictions were performed in the models incorporating training sets of experimentally in vivo tested molecules. The “CAESAR skin sensitisation” model in VEGA(Q)SAR software predicted that 1,5-dinitronapthalene has skin sensitiser potential with good reliability (Applicability Domain Index, AD=0.93) for the prediction. The model predicts this endpoint based on grouping of similar molecules with positive data in the murine local lymph node assay (LLNA). Other in vivo skin sensitisation models available in the Danish (Q)SAR database –allergic contact dermatitis in guinea pig and human gave a “POS_IN” result from specific endpoints of CASE Ultra, and SciQSAR.
The (Q)SAR data generated with specific models to estimate in vivo skin sensitisation effects gave strong evidence that 1,5-dinitronapthalene has a skin sensitisation potential. This property seems to be related to a moderate electrophilic reactivity profile of this molecule as suggested by the results obtained in the OECD Toolbox model “Direct Peptide Reactivity Assay”- DPRA. The DPRA is a standardised OECD test (TG 442C) to provide information on the molecular initiation events of skin sensitisers using synthetic heptapeptides containing cysteine and lysine amino acids. The estimated result revealed that 1,5-dinitonapthelene can bind to both these amino acids with DPRA potency of 13% in both cases.
Other factors not covered by the (Q)SAR models, such as hydrophobicity extrapolated by the Log P, were also considered in the evaluation. Specifically, the Log P of 2.8 estimated in DEREK Nexus for 1,5-dinitronapthalene is within the range of values that facilitate penetration into the human skin (EC, 2003).
Assessment of the quality of predictions: The skin sensitisation prediction in VEGA(Q)SAR was inside the applicability domain of the model and the overall assessment gave an AD index close to 1 (i.e., 0.903). The skin sensitisation prediction in the Consensus model available in the Danish QSAR database gave a result “POS_IN” which is an indication that the tested molecule was inside the applicability domain of this model.
General follow-up procedure: Despite the lack of animal testing data for this endpoint, the weight of evidence approach suggests classification of 1,5-dinotronapthalene as a skin sensitiser category 1B.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The (Q)SAR data generated with specific models to estimate in vivo skin sensitisation effects gave strong evidence that 1,5-dinitronapthalene has a skin sensitisation potential. This property seems to be related to a moderate electrophilic reactivity profile of this molecule as suggested by the results obtained in the OECD Toolbox model “Direct Peptide Reactivity Assay”- DPRA. The DPRA is a standardised OECD test (TG 442C) to provide information on the molecular initiation events of skin sensitisers using synthetic heptapeptides containing cysteine and lysine amino acids. The estimated result revealed that 1,5-dinitonapthelene can bind to both these amino acids with DPRA potency of 13% in both cases.
Other factors not covered by the (Q)SAR models, such as hydrophobicity extrapolated by the Log P, were also considered in the evaluation. Specifically, the Log P of 2.8 estimated in DEREK Nexus for 1,5-dinitronapthalene is within the range of values that facilitate penetration into the human skin (EC, 2003).
Assessment of the quality of predictions: The skin sensitisation prediction in VEGA(Q)SAR was inside the applicability domain of the model and the overall assessment gave an AD index close to 1 (i.e., 0.903). The skin sensitisation prediction in the Consensus model available in the Danish QSAR database gave a result “POS_IN” which is an indication that the tested molecule was inside the applicability domain of this model.
General follow-up procedure: Despite the lack of animal testing data for this endpoint, the weight of evidence approach suggests classification of 1,5-dinotronapthalene as a skin sensitiser category 1B. - Executive summary:
The (Q)SAR data generated with specific models to estimate in vivo skin sensitisation effects gave strong evidence that 1,5-dinitronapthalene has a skin sensitisation potential. This property seems to be related to a moderate electrophilic reactivity profile of this molecule as suggested by the results obtained in the OECD Toolbox model “Direct Peptide Reactivity Assay”- DPRA. The DPRA is a standardised OECD test (TG 442C) to provide information on the molecular initiation events of skin sensitisers using synthetic heptapeptides containing cysteine and lysine amino acids. The estimated result revealed that 1,5-dinitonapthelene can bind to both these amino acids with DPRA potency of 13% in both cases.
Other factors not covered by the (Q)SAR models, such as hydrophobicity extrapolated by the Log P, were also considered in the evaluation. Specifically, the Log P of 2.8 estimated in DEREK Nexus for 1,5-dinitronapthalene is within the range of values that facilitate penetration into the human skin (EC, 2003).
Assessment of the quality of predictions: The skin sensitisation prediction in VEGA(Q)SAR was inside the applicability domain of the model and the overall assessment gave an AD index close to 1 (i.e., 0.903). The skin sensitisation prediction in the Consensus model available in the Danish QSAR database gave a result “POS_IN” which is an indication that the tested molecule was inside the applicability domain of this model.
General follow-up procedure: Despite the lack of animal testing data for this endpoint, the weight of evidence approach suggests classification of 1,5-dinotronapthalene as a skin sensitiser category 1B.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.